471 related articles for article (PubMed ID: 28628639)
21. Olaparib modulates DNA repair efficiency, sensitizes cervical cancer cells to cisplatin and exhibits anti-metastatic property.
Prasad CB; Prasad SB; Yadav SS; Pandey LK; Singh S; Pradhan S; Narayan G
Sci Rep; 2017 Oct; 7(1):12876. PubMed ID: 28993682
[TBL] [Abstract][Full Text] [Related]
22. [Flap endonuclease-1 and its role in the processes of DNA metabolism in eucaryotic cells].
Nazarkina ZhK; Lavrik OI; Khodyreva SN
Mol Biol (Mosk); 2008; 42(3):405-21. PubMed ID: 18702299
[TBL] [Abstract][Full Text] [Related]
23. Disruption of SLX4-MUS81 Function Increases the Relative Biological Effectiveness of Proton Radiation.
Liu Q; Underwood TSA; Kung J; Wang M; Lu HM; Paganetti H; Held KD; Hong TS; Efstathiou JA; Willers H
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):78-85. PubMed ID: 27084631
[TBL] [Abstract][Full Text] [Related]
24. Inhibiting the MCM8-9 complex selectively sensitizes cancer cells to cisplatin and olaparib.
Morii I; Iwabuchi Y; Mori S; Suekuni M; Natsume T; Yoshida K; Sugimoto N; Kanemaki MT; Fujita M
Cancer Sci; 2019 Mar; 110(3):1044-1053. PubMed ID: 30648820
[TBL] [Abstract][Full Text] [Related]
25. Kinetics of endogenous mouse FEN1 in base excision repair.
Kleppa L; Mari PO; Larsen E; Lien GF; Godon C; Theil AF; Nesse GJ; Wiksen H; Vermeulen W; Giglia-Mari G; Klungland A
Nucleic Acids Res; 2012 Oct; 40(18):9044-59. PubMed ID: 22810208
[TBL] [Abstract][Full Text] [Related]
26. Small-Molecule Inhibitors Targeting FEN1 for Cancer Therapy.
Yang F; Hu Z; Guo Z
Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883563
[TBL] [Abstract][Full Text] [Related]
27. Detection of impaired homologous recombination repair in NSCLC cells and tissues.
Birkelbach M; Ferraiolo N; Gheorghiu L; Pfäffle HN; Daly B; Ebright MI; Spencer C; O'Hara C; Whetstine JR; Benes CH; Sequist LV; Zou L; Dahm-Daphi J; Kachnic LA; Willers H
J Thorac Oncol; 2013 Mar; 8(3):279-86. PubMed ID: 23399959
[TBL] [Abstract][Full Text] [Related]
28. Loss of DNA Damage Response in Neuroblastoma and Utility of a PARP Inhibitor.
Takagi M; Yoshida M; Nemoto Y; Tamaichi H; Tsuchida R; Seki M; Uryu K; Nishii R; Miyamoto S; Saito M; Hanada R; Kaneko H; Miyano S; Kataoka K; Yoshida K; Ohira M; Hayashi Y; Nakagawara A; Ogawa S; Mizutani S; Takita J
J Natl Cancer Inst; 2017 Nov; 109(11):. PubMed ID: 29059438
[TBL] [Abstract][Full Text] [Related]
29. Synergistic loss of prostate cancer cell viability by coinhibition of HDAC and PARP.
Chao OS; Goodman OB
Mol Cancer Res; 2014 Dec; 12(12):1755-66. PubMed ID: 25127709
[TBL] [Abstract][Full Text] [Related]
30. Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), enhances anti-tumor effects of the poly (ADP-ribose) polymerase (PARP) inhibitor olaparib in triple-negative breast cancer cells.
Min A; Im SA; Kim DK; Song SH; Kim HJ; Lee KH; Kim TY; Han SW; Oh DY; Kim TY; O'Connor MJ; Bang YJ
Breast Cancer Res; 2015 Mar; 17():33. PubMed ID: 25888415
[TBL] [Abstract][Full Text] [Related]
31. ATR Signaling Uncouples the Role of RAD51 Paralogs in Homologous Recombination and Replication Stress Response.
Saxena S; Dixit S; Somyajit K; Nagaraju G
Cell Rep; 2019 Oct; 29(3):551-559.e4. PubMed ID: 31618626
[TBL] [Abstract][Full Text] [Related]
32. PARG-deficient tumor cells have an increased dependence on EXO1/FEN1-mediated DNA repair.
Andronikou C; Burdova K; Dibitetto D; Lieftink C; Malzer E; Kuiken HJ; Gogola E; Ray Chaudhuri A; Beijersbergen RL; Hanzlikova H; Jonkers J; Rottenberg S
EMBO J; 2024 Mar; 43(6):1015-1042. PubMed ID: 38360994
[TBL] [Abstract][Full Text] [Related]
33. Human Fanconi anemia complementation group a protein stimulates the 5' flap endonuclease activity of FEN1.
Qian L; Yuan F; Rodriguez-Tello P; Padgaonkar S; Zhang Y
PLoS One; 2013; 8(12):e82666. PubMed ID: 24349332
[TBL] [Abstract][Full Text] [Related]
34. Microsatellite instability induced mutations in DNA repair genes CtIP and MRE11 confer hypersensitivity to poly (ADP-ribose) polymerase inhibitors in myeloid malignancies.
Gaymes TJ; Mohamedali AM; Patterson M; Matto N; Smith A; Kulasekararaj A; Chelliah R; Curtin N; Farzaneh F; Shall S; Mufti GJ
Haematologica; 2013 Sep; 98(9):1397-406. PubMed ID: 23349304
[TBL] [Abstract][Full Text] [Related]
35. Rad51 Degradation: Role in Oncolytic Virus-Poly(ADP-Ribose) Polymerase Inhibitor Combination Therapy in Glioblastoma.
Ning J; Wakimoto H; Peters C; Martuza RL; Rabkin SD
J Natl Cancer Inst; 2017 Mar; 109(3):1-13. PubMed ID: 28376211
[TBL] [Abstract][Full Text] [Related]
36. The Importance of Poly(ADP-Ribose) Polymerase as a Sensor of Unligated Okazaki Fragments during DNA Replication.
Hanzlikova H; Kalasova I; Demin AA; Pennicott LE; Cihlarova Z; Caldecott KW
Mol Cell; 2018 Jul; 71(2):319-331.e3. PubMed ID: 29983321
[TBL] [Abstract][Full Text] [Related]
37. Flap endonuclease 1: a central component of DNA metabolism.
Liu Y; Kao HI; Bambara RA
Annu Rev Biochem; 2004; 73():589-615. PubMed ID: 15189154
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of homologous recombination by treatment with BVDU (brivudin) or by RAD51 silencing increases chromosomal damage induced by bleomycin in mismatch repair-deficient tumour cells.
Vernole P; Muzi A; Volpi A; Dorio AS; Terrinoni A; Shah GM; Graziani G
Mutat Res; 2009 May; 664(1-2):39-47. PubMed ID: 19428379
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of poly (ADP-ribose) polymerase activates ATM which is required for subsequent homologous recombination repair.
Bryant HE; Helleday T
Nucleic Acids Res; 2006; 34(6):1685-91. PubMed ID: 16556909
[TBL] [Abstract][Full Text] [Related]
40. Augmented antitumor activity by olaparib plus AZD1775 in gastric cancer through disrupting DNA damage repair pathways and DNA damage checkpoint.
Lin X; Chen D; Zhang C; Zhang X; Li Z; Dong B; Gao J; Shen L
J Exp Clin Cancer Res; 2018 Jun; 37(1):129. PubMed ID: 29954437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
